PPT-International Summit of Human Gene Editing

December 2 2015 Gary E Marchant PhD JD g arymarchantasuedu Human Gene Editing International Governance Arguments for International Governance International standards assure equal protection for citizens of all nations. OR&GS WORKSHOP, 2014. Presented by Rachel Robertson. Thanks to Ian Chalmers for some of the slides. INTRODUCTION. Standards for editing. Who does what? . Editing your thesis. What examiners look for. . Fyodor D. Urnov, PhD. Project Leader and Senior Scientist, Sangamo BioSciences, Inc.. NAS International . Summit on Human Gene . Editing. December 3, 2015. Genome Editing . Is. In the Clinic. Fyodor D. Urnov, PhD. . Committee on Human Gene Editing: . Scientific, Medical and Ethical Considerations . Consensus Study Meeting #2 . February 11, 2016 . Philip E. Yeske, Ph.D.. Science & Alliance Officer. United Mitochondrial Disease Foundation. Fyodor D. Urnov, PhD. Project Leader and Senior Scientist, Sangamo BioSciences, Inc.. NAS International . Summit on Human Gene . Editing. December 3, 2015. Genome Editing . Is. In the Clinic. Fyodor D. Urnov, PhD. . Prof. . Zhihong. Xu, . Peking . University & Chinese Academy of Sciences . Outline. Policy . and . National Regulation. Publications and . Funding. Suggestions from CAS and . Society. 2003. Ethics Guidelines of Human Embryonic Stem Cell Research. medical marvel. . COPYRIGHT. Gene editing: a primer . Type of genetic engineering that modifies the genomic makeup of an organism. Early stages of this technology dealt with strictly micro applications:. Farm Policy Study Group. Gene Editing & the Seed Industry. December 4, 2018. 1. Your Future is our Foundation. 2. Traditional Plant Breeding. Gene Editing in Context. 3. “Traditional” Plant Breeding. Andrew May DPhil Chief Scientific Officer Caribou Biosciences, Inc. 2/11/2016 1 Gene Editing Tools and Methods Caribou background Founded by Jennifer Doudna , Rachel Haurwitz , Martin Jinek and James Berger (UC Berkeley) to develop commercial applications Genomics. Lesson 12. , presentation 3. Hardison. (many slides from Dr. . Cooduvalli. . Shashikant. ). 4/26/15. 1. Genome Editing . Removal, modification, or addition of a functional element into the genome of a living cell or organism. Describe the Gene Editing Technology (CRISPR-Cas9, ZNF, TALENS, Meganucleases) . Describe . the target gene, function of the target gene. and . the desired effect of the target gene in the system (in-vitro/in vivo) . 12 – 13 November 2019, Singapore. www.gfbr.global.  .  .  .  . The GFBR. Funded by Bill & Melinda Gates Foundation, UK Medical Research Council, US National Institutes of Health, and . Wellcome. Propelled by the promise of faster, cheaper, and more accurate by CRISPR-Cas gene editing. For all of their ease and rapidity, cell or gene therapy. The generation of unintended DNA strand its niche w Ethics, governance and policy aspects of human genome editing research . . Maneesha S Inamdar. JNCASR, Bangalore. GFBR. 12-13 Nov 2019. Singapore. Maneesha S Inamdar. Professor and Chair. Molecular Biology and Genetic Unit. Evidence-based Messaging For. GENE EDITING. QUOTE GOES HERE. Lorem ipsum dolor sit ametersi, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt utslid laoreet dolore magna aliquam erat minim veniaem, quisuroer slides nostrud exerci tation ullamcorper suscipit lobortisi aleaiquip exeacts commodo consequat. Lorem ipsum dolor siti slide amet suscipit lobortis nislutres aliquip exeact commodo. .